Surgery Versus Radiofrequency Ablation for Early Recurrence of Hepatocellular Carcinoma : Impact of Risk Prediction Model for Microvascular Invasion

被引：0
|
作者：
Lee, Sunyoung [1 ]
Kang, Tae Wook [2 ]
机构：
[1] Yonsei Univ, Severance Hosp, Coll Med, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1523
引用
收藏
页码：868A / 868A
页数：1
相关论文
共 50 条
  • [41] Evaluation of a serum tumour marker-based recurrence prediction model after radiofrequency ablation for hepatocellular carcinoma
    Yoo, Jeongin
    Lee, Min Woo
    Lee, Dong Ho
    Lee, Jeong-Hoon
    Han, Joon Koo
    LIVER INTERNATIONAL, 2020, 40 (05) : 1189 - 1200
  • [42] PREDICTION OF MICROVASCULAR INVASION BEFORE SURGERY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA: A NOMOGRAM MODEL BASED ON INFLAMMATORY MARKERS
    Zeng, Qianwen
    Xiao, Han
    Wu, Tingfan
    Li, Xin
    Peng, Sui
    Kuang, Ming
    GUT, 2020, 69 : A78 - A78
  • [43] Nomograms established for predicting microvascular invasion and early recurrence in patients with small hepatocellular carcinoma
    Wang, Xi
    Chai, Xinqun
    Zhang, Ji
    Tang, Ruiya
    Chen, Qinjunjie
    BMC CANCER, 2024, 24 (01)
  • [44] Microvascular Invasion in Small-sized Hepatocellular Carcinoma: Significance for Outcomes Following Hepatectomy and Radiofrequency Ablation
    Imai, Katsunori
    Yamashita, Yo-Ichi
    Yusa, Toshihiko
    Nakao, Yosuke
    Itoyama, Rumi
    Nakagawa, Shigeki
    Okabe, Hirohisa
    Chikamoto, Akira
    Ishiko, Takatoshi
    Baba, Hideo
    ANTICANCER RESEARCH, 2018, 38 (02) : 1053 - 1060
  • [45] Is serum endocan a sensitive biomarker for early recurrence of hepatocellular carcinoma after radiofrequency ablation?
    Omar, Seham A.
    Attia, Nahla M.
    Sheir, Mohamed I.
    Amer, Ayman S.
    EL Shabrawy, Mohamed M.
    Hasan, Basma B.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (07) : 1015 - 1022
  • [46] Risk factors of recurrence and poor survival in curatively resected hepatocellular carcinoma with microvascular invasion
    Zhou, Li
    Wang, Shao-Bin
    Chen, Shu-Guang
    Qu, Qiang
    Rui, Jing-An
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 29 (07): : 887 - 892
  • [47] Percutaneous radiofrequency ablation for hepatocellular carcinoma: Early termination versus standard termination of ablation procedure
    Cheng, Ya-Ting
    Ong, Arlinking
    Lin, Chen-Chun
    Lin, Chun-Jung
    Chen, Wei-Ting
    Lin, Shi-Ming
    ADVANCES IN DIGESTIVE MEDICINE, 2016, 3 (04) : 167 - 173
  • [48] Serum ferritin level as a risk factor for hepatocellular carcinoma recurrence after radiofrequency ablation
    Uchino, Koji
    Nakagawa, Hayato
    Tateishi, Ryosuke
    Kondo, Mayuko
    Fujiwara, Naoto
    Minami, Tatsuya
    Sato, Masaya
    Enooku, Kenichiro
    Kondo, Yuji
    Asaoka, Yoshinari
    Yoshida, Haruhiko
    Shiina, Shuichiro
    Koike, Kazuhiko
    HEPATOLOGY, 2013, 58 : 1255A - 1255A
  • [49] Recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: Analysis of the pattern and risk factors
    Chen, Rui
    Hou, Beining
    Zhou, Yanzhao
    Zhang, Tuo
    Wang, Zhengzheng
    Chen, Xun
    Zhang, Yingwei
    Chen, Man
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [50] Hepatic Resection Versus Radiofrequency Ablation for Very Early Stage Hepatocellular Carcinoma: A Markov Model Analysis
    Cho, Yun Ku
    Kim, Jae Kyun
    Kim, Wan Tae
    Chung, Jin Wook
    HEPATOLOGY, 2010, 51 (04) : 1284 - 1290
12345